Showing results (911-920 of 945) with videos related to

Sort By:
Pageof 95
Scientific Reports|October 25, 2016
Basal Tumor Cell Isolation and Patient-Derived Xenograft Engraftment Identify High-Risk Clinical Bladder CancersK B Skowron, S P Pitroda, J P Namm, et al.
BMC Cancer|November 19, 2023
Protocol of the Comparison of Intravesical Therapy and Surgery as Treatment Options (CISTO) study: a pragmatic, prospective multicenter observational cohort study of recurrent high-grade non-muscle invasive bladder cancerJohn L Gore, Erika M Wolff, Bryan A Comstock, et al.
Biorxiv : the Preprint Server for Biology|November 24, 2025
Carbohydrate adaptation drives liver-brain axis maturationHongmei Cui, Zheng Wu, Yuannyu Zhang, et al.
Urologic Oncology|May 21, 2020
Variability in adherence to guidelines based management of nonmuscle invasive bladder cancer among Society of Urologic Oncology (SUO) membersJustin T Matulay, William Tabayoyong, Jonathan J Duplisea, et al.
Plos One|May 17, 2012
Loss of the urothelial differentiation marker FOXA1 is associated with high grade, late stage bladder cancer and increased tumor proliferationDavid J DeGraff, Peter E Clark, Justin M Cates, et al.
European Urology|March 18, 2014
Alvimopan accelerates gastrointestinal recovery after radical cystectomy: a multicenter randomized placebo-controlled trialCheryl T Lee, Sam S Chang, Ashish M Kamat, et al.
The Journal of Urology|October 25, 2021
Utility of Blue Light Cystoscopy for Post-bacillus Calmette-Guérin Bladder Cancer Recurrence Detection: Implications for Clinical Trial Recruitment and Study ComparisonsMeera R Chappidi, Heiko Yang, Maxwell V Meng, et al.
European Urology|July 7, 2020
Reporting Radical Cystectomy Outcomes Following Implementation of Enhanced Recovery After Surgery Protocols: A Systematic Review and Individual Patient Data Meta-analysisStephen B Williams, Marcus G K Cumberbatch, Ashish M Kamat, et al.
The Journal of Urology|December 18, 2013
Alvimopan, a peripherally acting μ-opioid receptor antagonist, is associated with reduced costs after radical cystectomy: economic analysis of a phase 4 randomized, controlled trialTeresa L Kauf, Robert S Svatek, Gilad Amiel, et al.
Cancers|April 13, 2024
Racial Differences in the Detection Rate of Bladder Cancer Using Blue Light Cystoscopy: Insights from a Multicenter RegistrySeyedeh-Sanam Ladi-Seyedian, Alireza Ghoreifi, Badrinath Konety, et al.
Pageof 95